Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host cell transcriptional machinery at the human osteocalcin promoter refers to the multi-protein assembly responsible for the expression of the BGLAP gene, which encodes osteocalcin (Stein et al., 2004; PubMed ID: 15190401). This machinery includes RNA polymerase II, general transcription factors, and specific regulatory proteins such as Runx2 and the Vitamin D Receptor (VDR) (Lian et al., 1999; PubMed ID: 10352948). Osteocalcin is a vital bone-matrix protein that plays a significant role in bone mineralization and acts as a hormone influencing systemic glucose metabolism. The assembly of this transcriptional complex is a primary site for the integration of physiological signals, most notably from 1,25-dihydroxyvitamin D3 and glucocorticoids (Pike & Meyer, 2010; PubMed ID: 20139295). Dysregulation of this machinery is a hallmark of various metabolic bone disorders, including osteoporosis and osteopetrosis. While the machinery itself is a broad cellular apparatus, its specific recruitment to the osteocalcin promoter is a focal point for understanding how drugs like calcitriol promote bone health. Therapeutic strategies typically target the individual transcription factors that guide this machinery to the promoter rather than the machinery as a whole. Consequently, this entry is classified as incorrect in a therapeutic context because it describes a localized biological process or site of action rather than a single druggable molecule.
Modulation of the recruitment and activity of the RNA polymerase II holoenzyme and associated co-activators at the BGLAP gene locus through nuclear receptor binding.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human osteocalcin promoter transcriptional complex (BGLAP promoter complex).